|
Volumn 30, Issue 1, 1988, Pages 1-6
|
A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLEOMYCIN;
CISPLATIN;
MITOMYCIN;
VINCRISTINE;
ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CLINICAL ARTICLE;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METASTASIS;
PRIORITY JOURNAL;
UTERINE CERVIX CARCINOMA;
ADENOCARCINOMA;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
CARCINOMA, SQUAMOUS CELL;
CERVIX NEOPLASMS;
CISPLATIN;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
FEMALE;
HUMAN;
MIDDLE AGE;
MITOMYCINS;
NEOPLASM STAGING;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
VINCRISTINE;
|
EID: 0023877727
PISSN: 00908258
EISSN: 10956859
Source Type: Journal
DOI: 10.1016/0090-8258(88)90038-8 Document Type: Article |
Times cited : (55)
|
References (15)
|